Use of Theater to Invoke Empathy and Reduce Bias in Medical Students
NCT ID: NCT01739257
Last Updated: 2023-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
129 participants
INTERVENTIONAL
2012-08-31
2012-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Online Education Intervention to Reduce Ageism Among Undergraduate Students
NCT04570917
Impact of Narrative Medicine (Workshop Reading Diaries)
NCT01798290
Enhancing Empathy in Medical Communication Through Perspective-Taking
NCT00861991
Impact of Narrative Medicine (Workshop Reflexive Writing)
NCT01798069
A Brief Intervention to Improve Cost-effective Resource Use Among Medicine Housestaff
NCT01303263
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Theater
1-hour dramatic reading of "The Most Massive Woman Wins"
Dramatic Reading
Lecture
1-hour lecture on the medical management of obese patients
Medical Lecture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medical Lecture
Dramatic Reading
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Arnold P. Gold Foundation
OTHER
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard L Kravitz, MD, MSPH
Role: PRINCIPAL_INVESTIGATOR
UC Davis School of Medicine
Rachel Hammer, BA
Role: STUDY_DIRECTOR
Mayo Medical School
Johanna Shapiro, PhD
Role: STUDY_DIRECTOR
UC Irvine School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UC Davis School of Medicine
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
254423
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.